Focus Investment Banking

AUGUST 15, 2023

Washington, DC, (August 15, 2023) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that it has added two new managing directors, Mike McCraw and William R. Bill”) Snow.

Investment Banking 52

Investment Banking Bank Banking Management 52

Focus Investment Banking

DECEMBER 26, 2023

His work includes business sales and capital raises for middle-market companies as well as buy-side services for acquirers seeking middle-market companies. The post Recap: 2023 Midwest M&A/Private Equity Forum appeared first on FOCUS Investment Banking LLC. Contact Bill at William.snow@focusbankers.com.

Private Equity 52

Private Equity M&A Equities Insurance 52

Sica Fletcher

JULY 1, 2020

No one really knows how the pandemic will play out from a medical, economic, political, and societal perspective. The answer relates to private equity and the availability of capital to fund acquisitions and the need to deploy this capital. We face a future of uncertainty. PE-backed deal flow declined somewhat in 2019.

Private Equity 52

Private Equity Insurance Debt Equities 52

Growth Business

SEPTEMBER 13, 2023

By Rory Bennett on Growth Business - Your gateway to entrepreneurial success On the face of it, Britain’s venture capital firms have never been more ready to invest in your start-up. Last year, venture capital raised £6.8 Capital invested by venture capital trusts increased by 8 per cent last year to £664 million.

Capital 52

Capital Business Funds Investment 52

Focus Investment Banking

DECEMBER 21, 2023

His work includes business sales and capital raises for middle-market companies as well as buy-side services for acquirers seeking middle-market companies. The post 2023 End of Year Bits and Pieces appeared first on FOCUS Investment Banking LLC. Contact Bill at William.snow@focusbankers.com.

M&A 52

M&A Middle Market Economics IT 52

Mergers and Inquisitions

MARCH 5, 2025

In technology, as a startup keeps raising capital, it normally does so at gradually higher valuations as its customers, users, and revenue grow. But in biotech, companies valuations often remain close to their total capital raised until much later in the process (i.e., or Ph.D.),

Funds 64

Funds Healthcare Mergers and Acquisitions Valuation 64